The authors begin from an uncomfortable observation: decades of behavior change research, from the theory of planned behavior to self-determination theory and socioecological models, explain only a modest proportion of the differences in physical behavior between and within individuals. People are notoriously inconsistent—one week they jog daily, the next they barely leave the sofa. The researchers attribute this weak predictive power to three structural shortcomings in existing models. First, most frameworks focus either on the short-term determinants that drive behavior or on the long-term health consequences that flow from it, rarely both. Second, they overlook the fact that consequences can loop back and become determinants: fitness gained through months of exercise also shapes how active you feel like being tomorrow. Third, and most fundamentally, they ignore the arithmetic of the day itself.

That arithmetic is unforgiving. Sleep, sedentary behavior, and physical activity are locked together within the fixed 1,440 minutes available, so every additional minute spent in one behavior must come at the expense of another. A person who adds thirty minutes of morning running necessarily removes thirty minutes from sleep, sitting, or some other activity. Traditional single-behavior studies, which examine physical activity in isolation, cannot capture these trade-offs. The new model builds on earlier 24-hour frameworks—including Pedišić’s Activity Balance Model, the Framework for Viable Integrative Research in Time-Use Epidemiology, and Rosenberger and colleagues’ 24-hour Activity Cycle—but goes further by explicitly embedding the full daily composition within a dual-process psychological architecture and a health-outcome architecture, connected by eight distinct pathways labeled A through H.

The left side of the model, adapted from the neurocognitive affect-related model, describes how the brain’s moment-to-moment machinery shapes what we do with our time. Its central constructs are affective states and executive functions. Following the work of Duncan and Barrett, the authors treat affect as a neurophysiological state defined by two dimensions: valence, the pleasantness or unpleasantness of a feeling, and energetic arousal, the level of activation. Executive functions, as defined by Diamond, encompass inhibition control, working memory, and cognitive flexibility—the mental capacities that let us plan, resist temptation, and stay focused on long-term goals despite distractions. The model proposes that optimal daily compositions of sleep, sitting, and activity can enhance these executive functions, which in turn foster more positive affective responses, which then facilitate healthier future behavior compositions.

Crucially, these pathways are reciprocal. Pathway A suggests that executive-function-based cognition shapes the emotional responses induced by exercise or prolonged sitting; pathway B connects those emotional responses to the future balance of daily behaviors, since affective reactions during a workout predict whether a person returns to exercise. Pathways C and D close the loop: cognitive preparation such as time management and goal setting influences the day’s activity composition, while the composition itself—regular exercise, adequate sleep—feeds back to improve cognitive function. The authors also acknowledge bidirectionality in the reverse direction, noting that physical behavior can predict momentary affect and that momentary affect can predict executive function performance, making the entire left side of the model a dynamic, self-modifying system rather than a one-way causal chain.

The right side of the model, adapted from the health model of Bouchard, Blair, and Haskell, traces the physiological consequences. Here the claim is that an optimal daily composition improves health-related fitness markers such as cardiorespiratory fitness (pathway E), which then improves the state of physical and mental health, from well-being to mortality risk (pathway F). The evidence base for these links is substantial. A systematic review of fifty-six isotemporal substitution studies concluded that reallocating time between sleep, sedentary behavior, light-to-moderate activity, and moderate-to-vigorous activity is associated with numerous health outcomes. A meta-analysis further showed that short sleep is significantly linked to mortality, diabetes, cardiovascular disease, coronary heart disease, and obesity. These pathways, too, can run backward: fitness markers predict individual behaviors, health status predicts fitness, and illness or injury—captured by pathway H—can abruptly reshape the whole day, as anyone with a broken leg who suddenly spends far more time sleeping and sitting can attest.

What distinguishes this framework from its predecessors is its insistence on temporal resolution. The authors divide the eight pathways into short-term dynamics operating within days, medium-term associations across weeks and months, long-term effects over years, and mixed pathways spanning days to years. Affective states fluctuate hour to hour and even minute to minute, so pathways A, B, and C demand high-granularity, real-world data. The state-of-the-art tool here is ambulatory assessment: smartphone-based electronic diaries capturing real-time self-reports, paired with wearable sensors measuring the full 24-hour behavior composition objectively and repeatedly. This approach preserves ecological validity and avoids the retrospective biases that plague questionnaire studies. By contrast, the fitness pathway E requires weeks or months of observation, ideally through randomized interventions with repeated and follow-up measurements, while the health pathways F and G unfold over years and call for long-term cohort studies—one 18-year community study found that habitual physical activity related positively to both fitness and health status decades later.

The model also arrives at a moment when the statistical machinery for 24-hour research has matured. Compositional data analysis treats sleep, sedentary time, and activity as parts of a finite whole, analyzing them relative to one another rather than as independent variables, and the compositional isotemporal substitution method estimates what happens to a health outcome when a fixed block of time is shifted from one behavior to another. The empirical payoff is already visible. In an analysis of six cross-sectional studies covering 15,253 participants, moderate-to-vigorous physical activity showed the strongest and most time-efficient protective associations with cardiometabolic outcomes, while sedentary behavior was the only behavior with clearly adverse associations regardless of duration. The Maastricht Study, with 2,388 participants, found that less sitting and more standing, physical activity, and sleep were associated with better cardiometabolic health and glycaemic control. Device-based measurement via wearables now makes it possible to capture every facet of the daily composition with time-stamped precision, and the model’s components can be refined as needed—splitting activity into standing, light, and vigorous categories, or sleep into REM and non-REM stages, or even distinguishing outdoor from indoor activity.

The long-term ambition is strikingly concrete: to identify the optimal balance of 24-hour behaviors that maximizes health benefits and promotes longevity and well-being. Tremblay and colleagues anticipate that the 24-hour approach will eventually underpin individualized, precision movement guidelines tailored to personal characteristics and circumstances—several countries and the World Health Organization already issue integrated 24-hour movement guidelines. The authors are careful to note that the relationships in their model are shaped by genetic predispositions, social and physical environments, and individual circumstances, which may moderate, mediate, or confound the pathways, so generalization demands caution. But by combining behavioral, affective, and health determinants and consequences in a single flexible framework, and by specifying exactly which timescale each hypothesis should be tested on, the 24-hour cognitive-affective physical behavior model gives researchers something previous theories did not: a shared map of the entire day, drawn to scale, with the clock built in.

Subject of Research: The 24-hour cognitive-affective physical behavior model: a theoretical framework for studying determinants and health consequences of physical activity, sedentary behavior, and sleep

Article Title: The 24-hour cognitive-affective physical behavior model: a theoretical framework for studying determinants and health consequences of physical activity, sedentary behavior, and sleep

Article References: Giurgiu, M., & Ebner-Priemer, U. W. (2025). The 24-hour cognitive-affective physical behavior model: a theoretical framework for studying determinants and health consequences of physical activity, sedentary behavior, and sleep. Journal of Activity, Sedentary and Sleep Behaviors, 4(1), Article 6. https://doi.org/10.1186/s44167-025-00077-9

Image Credits: AI Generated

DOI: 10.1186/s44167-025-00077-9

Keywords: hour, cognitive-affective, physical, behavior, model, theoretical, framework, studying, determinants, health, consequences, activity

The authors build their case from a series of revealing examples drawn from British screening history. The UK National Screening Committee recommended against population-based prostate cancer screening, concluding that while screening prevented prostate cancer deaths, it also caused harm through overdiagnosis and overtreatment, leaving some men with urinary incontinence or erectile dysfunction. In reaching that conclusion, the committee made a value judgement about how to weigh extended life against morbidity — and, the authors note, it assumed without evidence that individual men would share its values. Meanwhile, when Wales extended the cervical screening interval for women aged 25 to 49 from three years to five in 2022, a scientifically defensible decision triggered a public outcry and a petition signed by more than a million people, prompting England to delay the same change until July 2025.

Bowel screening illustrates how resources quietly shape supposedly clinical thresholds. The faecal immunochemical test, or FIT, applies a binary cut-off to the amount of blood in a stool sample, and that cut-off ranges from 8.5 to 150 micrograms of haemoglobin per gram of faeces across programmes, largely to manage colonoscopy capacity. Historically, Wales used a threshold of 150, England 120 and Scotland 80 micrograms per gram — meaning a result deemed normal in England could have triggered a colonoscopy just across the Scottish border. The stakes of delay are also stark: randomised trials showed guaiac-based faecal occult blood testing reduced colorectal cancer mortality as early as 1996, yet England’s screening programme only completed roll-out in 2010. Screening now prevents roughly 2,000 colorectal cancer deaths annually in England; had it rolled out in 2000, the authors estimate some 20,000 premature deaths could have been averted.

To make sense of such cases, Sasieni and John adapt five principles for decision-making under uncertainty — proportionality, justice, autonomy, feasibility and adaptability — into a framework specifically for cancer screening. Their central claim is that policymakers suffer from an asymmetry of fear: they worry intensely about false-positive decisions, such as introducing a screening programme that turns out to do more harm than good, while largely ignoring false-negative decisions, in which beneficial programmes are delayed or withheld. Because committees periodically revisit recommendations, a cautious ‘not yet’ feels reversible and safe. But delay has consequences that can be quantified even without certainty. If prostate screening in men aged 50 to 65 reduces prostate cancer mortality by 25 percent over 15 years, a two-decade implementation delay could translate into around 20,000 avoidable deaths in the UK. Conversely, had multimodal ovarian cancer screening been introduced for women aged 50 to 74 before the definitive UKCTOCS trial results, roughly 7,000 women each year might have undergone unnecessary surgery. Both sides of the ledger can be estimated, the authors argue, and should be before decisions are made.

The principle of justice exposes another hidden cost of slowness: inequality. Wealthy and well-educated people frequently obtain screening privately long before public programmes roll out. In the United States, colonoscopy use is 50 percent higher in the wealthiest socioeconomic quintile than in the poorest. In England, prostate-specific antigen testing is 25 percent lower in the most deprived quintile — and metastatic prostate cancer rates there are 11 percent higher, while overall prostate cancer incidence is 19 percent lower, plausibly reflecting inequitable access to asymptomatic PSA testing. Justice also complicates the details: some researchers argue FIT referral thresholds should differ for women and men, but the right answer depends on which measure of equity one chooses to prioritise, a value judgement that should be made transparently. Even overdiagnosis falls unevenly — introducing prostate screening for men in their seventies would generate more overdiagnosis among the most deprived, whose shorter life expectancy means more of them die of other causes before screening could ever help.

Autonomy poses a deeper philosophical problem. Public health typically overrides individual preferences for the collective good, while clinical medicine demands informed consent. Screening sits awkwardly between: society seeks consent before screening anyone, yet takes a paternalistic stance on what screening is offered at all, rarely considering the ethics of denying screening to those who want it. The authors suggest a more democratic division of labour, inspired by the Dutch model: expert committees could summarise evidence and uncertainties without issuing recommendations, forcing elected politicians to make the value-laden choices explicitly. Where experts disagree, politicians should decide. They even sketch a personalised option for prostate screening — inviting men aged 50 to 69 for triennial PSA testing without encouraging participation, letting personal risk tolerance guide the decision, much as oncology patients weigh their own treatment choices.

Feasibility, the authors stress, already governs screening policy whether it is admitted or not. FIT thresholds and age ranges are set by colonoscopy capacity; MRI-based prostate screening would demand vast new infrastructure of scanners and staff; and in low- and middle-income countries, cervical screening is constrained by the lack of facilities to triage screen-positive women and treat precancerous lesions. Public opinion constrains policy too — hence the continued offering of cervical screening at age 25 to women vaccinated against HPV as adolescents, despite their extremely low cervical cancer risk and the likelihood that screening does them more harm than good. The authors argue the public is mature enough to understand these trade-offs, provided they are communicated honestly.

Adaptability may be the most urgent principle in an era of artificial intelligence and liquid biopsies. Traditional screening trials are ruinously expensive — the National Lung Cancer Screening Trial cost 256 million dollars in 2002, roughly 400 million today — and a binary framework of full national implementation or complete rejection leaves no pathway for pragmatic pilots that generate evidence while delivering benefit. Multicancer detection tests sharpen the dilemma: by the time one test’s clinical utility is fully evaluated, the technology will be outdated, and trial designs that test each cancer type separately would require randomising millions of people. The authors call for publicly funded pilots designed to fill evidence gaps, with implementation beginning in health-deprived regions to address injustice rather than widen it. They are candid about the risks of permissiveness — a pilot ovarian screening programme before 2021 would have harmed some healthy women with false positives — but insist those harms and benefits could and should have been estimated in advance, and that any new decision-making system should itself be monitored and reformed if it fails.

The paper’s conclusion is disarmingly simple: presenting screening policy as a straightforward application of evidence-based medicine obscures profound ethical and political choices, and delaying a decision is itself a decision against change — one measured in preventable deaths, avoidable morbidity and widening inequality. As AI begins to exceed human radiologists and pathologists, quantifying future disease risk and optimising screening intervals, governance structures built around static population interventions and decade-long trials will be unable to evaluate products superseded every five years. Who decides, on what basis, and how quickly — the authors argue — are questions that can no longer be left unasked.

Subject of Research: Ethical and policy frameworks for cancer screening decision-making under uncertainty

Article Title: The clinical consequences of excessive caution: rethinking how cancer screening policy is made

Article References: Sasieni, P., & John, S. (2026). The clinical consequences of excessive caution: rethinking how cancer screening policy is made. eClinicalMedicine, Article 104188. https://doi.org/10.1016/j.eclinm.2026.104188

Image Credits: AI Generated

DOI: 10.1016/j.eclinm.2026.104188

Keywords: cancer screening, screening policy, decision-making under uncertainty, health inequalities, prostate cancer screening, bowel cancer screening, multicancer detection tests, artificial intelligence, overdiagnosis, public trust, clinical, consequences